EJCTS Click here to go to Edwards website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Arjuna Weerasinghe
Pandelis Philippidis
Jonathan Day
Kaushik Mandal
Jonathan Anderson
Kenneth Taylor
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weerasinghe, A.
Right arrow Articles by Taylor, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weerasinghe, A.
Right arrow Articles by Taylor, K.
Related Collections
Right arrow Cardiac - other
Right arrow Coronary disease
Right arrow Extracorporeal circulation
Right arrow Molecular biology

Eur J Cardiothorac Surg 2006;29:312-318
© 2006 Elsevier Science NL

Platelet–monocyte pro-coagulant interactions in on-pump coronary surgery

Arjuna Weerasinghe a , * , Thanos Athanasiou b , Pandelis Philippidis a , Jonathan Day a , Kaushik Mandal b , Oliver Warren b , Jonathan Anderson a , Kenneth Taylor a

a Department of Cardiac Surgery, Imperial College School of Medicine, University of London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK
b Department of Cardiac Surgery, Imperial College School of Medicine, University of London, St. Mary's Hospital, London, UK

Received 25 May 2005; received in revised form 25 October 2005; accepted 14 November 2005.

* Corresponding author: Tel.: +44 776 611 5590; fax: +44 208 740 7019. (Email: a.weerasinghe{at}ic.ac.uk).


    Abstract
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Discussion
 References
 
Objective: Platelets and monocytes possess haemostatic properties, but the clinical effect of platelet–monocyte interactions on haemostasis following coronary surgery is not known. The study characterises the platelet and monocyte responses in cardiac surgery and its impact on haemostasis. Methods: In 1342 patients, changes in white blood cell counts (WBC), monocyte counts and platelet counts were measured. PMC formation was analysed by flow-cytometry using monoclonal antibodies against pan-leucocyte marker CD45, monocyte marker CD14 and platelet marker CD42. TF expression was determined using monoclonal antibodies against, CD45, CD14 and human-TF. Continuous variables were expressed as mean ± SD. Changes in monocyte and platelet counts over time were considered as repeated measures data, and analysed using Generalised Estimating Equations (GEE). Multivariate regression analysis was used to evaluate the effect of several factors on blood loss. Results: A monocytosis occurs with on-pump coronary surgery, but is less pronounced than with off-pump surgery. No difference was seen in patients having redo-surgery or more complex cardiac surgery. Factors associated with monocytosis on multivariate analysis were higher body mass index (p = 0.02), diabetes (p = 0.035) and smoking (p = 0.01). Older patients manifested a lower response (p < 0.001). Cross-clamp fibrillation was associated with a lower (p = 0.048) monocytic response than was cardioplegia. PMC formation dropped following administration of heparin, peaked at 5 min of CPB, and declined by 2 h of CPB (p = 0.04). A return towards preoperative levels was found during postoperative days 1–5. No significant change in monocyte TF expression occurred. The mean postoperative blood loss was 581.2 ± 292.8 ml, and inversely related to increasing preoperative platelet counts (p < 0.001), and to higher monocyte % counts (p = 0.012). Patients, who were female (p < 0.001), had higher body mass indices (p < 0.001), and higher core body temperatures during surgery (p = 0.013), as well as patients having perioperative aprotinin (p < 0.001) related to less blood loss. Conclusions: A higher postoperative platelet count as well as monocyte% significantly and independently decreases postoperative blood loss following cardiac surgery.

Key Words: Platelets • Monocyte • Cardiopulmonary bypass • Coronary artery bypass surgery


    1. Introduction
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Discussion
 References
 
Circulating platelets and monocytes possess direct haemostatic properties that may become activated during coronary surgery. Studies suggest that platelet-derived tissue factor (TF), associated with platelet–monocyte conjugate (PMC) formation, or transcriptionally derived monocyte TF is responsible for potentiating coagulation [1,2].

Interestingly, only 10–20% of the total extractable tissue factor activity is expressed on the surface of intact monocytes. Thus, most TF is latent or encrypted in the cell membrane. Platelets, through platelet-derived microparticles are a source of tissue factor to circulating monocytes, resulting in rapid pro-coagulant responses. These involve the formation of thrombin via a TF/factor VII-dependent and factor XII-independent pathway [3].

In contrast, a delayed, transcriptionally mediated monocyte TF expression is thought to involve not only platelet interaction but also stimulation by circulating cytokines generated perioperatively. When co-incubated, leucocytes and platelets generate more TF activity than either cell type alone. Platelets play a pivotal role in decrypting TF activity of monocytes, generating a hybrid TF terrain, which both triggers and favours thrombogenesis [4].

Despite the awareness of these platelet–monocyte coagulant interactions, it is not known whether these monocytic and platelet count changes are related to the complexity of procedure performed and the use of cardiopulmonary bypass, and also if they have a clinically significant impact on haemostasis following conventional on-pump coronary surgery.

The specific objectives of this study were to

(1) ascertain if the complexity of the procedure affected the monocytic and platelet count changes?
(2) ascertain if there was a difference between on- and off-pump coronary artery bypass grafting in terms of monocytic and platelet count changes?
(3) characterise elements of the monocytic response elicited by cardiac surgery that potentially relate to haemostasis, and to determine whether preoperative and/or intraoperative factors influenced this response?
(4) characterise the interaction between monocytes and platelets after conventional on-pump coronary surgery?
(5) ascertain if there was a clinically discernable influence on haemostatic outcome after on-pump coronary surgery that confirmed the known potential haemostatic nature of these interactions between monocytes and platelets?


    2. Materials and methods
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Discussion
 References
 
2.1 Patient selection
The computerised prospective cardiac surgical database at the Hammersmith Hospital, London, maintains data on cardiac operations performed at the Hospital. One thousand and forty-two consecutive patients having isolated first time coronary artery bypass graft surgery were selected for inclusion into the main study group. We also selected a secondary study group including 300 of the most recent consecutive cardiac surgery patients having first time or redo surgery at St. Mary's Hospital.

Preoperative and postoperative white blood cell counts, monocyte counts and platelet counts were measured on all patients as part of their automated full blood count. Monocyte counts were expressed as a percentage of the total white cell count to give the monocyte percentage, thus aiming to detect if a relative monocytosis occurred following surgery and to differentiate this from a rise reflecting an overall leucocytosis. The preoperative and intraoperative variables used for the multivariate models in the study are shown in Table 1 along with the distribution of patients within each variable.


View this table:
[in this window]
[in a new window]
 
Table 1. Descriptive statistics of study population
 
2.2 Surgical techniques
2.2.1 On-pump technique, Hammersmith Hospital
Cardiopulmonary bypass was performed using aorto-caval cannulation, a Stockert roller pump (Stockert Instrumente, Munich) and a Bard or Quadrox hollow fibre membrane oxygenator (Jostra Medizintechnik AG, Germany). The mean cardiopulmonary bypass time was 80.45 ± 27.45 min and the mean cross-clamp time was 42.75 ± 19.70 min. The method of myocardial protection was cardioplegia in 584 (56%) patients and cross-clamp fibrillation in the remaining 458 (44%). The mean blood pressure on cardiopulmonary bypass was maintained at 50–60 mmHg. The lowest core temperature whilst on cardiopulmonary bypass in degree Celsius was noted as the core temperature of the body during the operation.

2.2.2 On-pump technique, St. Mary's Hospital
CPB was instituted with aorto-caval cannulation. Standard bypass management included membrane oxygenators, arterial line filters and, non-pulsatile flow of 2.4 l/min/m2 with a mean arterial blood pressure 50–60 mmHg. Myocardial protection was achieved mainly by intermittent antegrade cold blood cardioplegia (4:1 blood to crystalloid ratio). Retrograde blood cardioplegia was used occasionally in addition, particularly if there was left main stem disease with tight right coronary artery stenosis, which might cause inadequate delivery of the cardioplegia to the targeted myocardium and consequently incomplete myocardial protection. Temperature management was again with moderate hypothermia.

2.2.3 Off-pump technique, St. Mary's Hospital
Off pump surgery was performed with proximal occlusion of the target coronary vessel with a silastic sling and the use of epicardial stabilising devices and apical suction devices [Octopus® 3 or 4 (Medronic Inc., Minneapolis, USA), StarfishTM (Medronic Inc.) or the Guidant Vortex Vacuum Assist (Cupertino, USA)]. Intracoronary shunts were not used routinely during the distal anastomoses. Systolic arterial pressures were maintained at a minimum of 70 mmHg during distal anastomoses utilising venous volume regulation, rate control, inotropes or vasoconstrictors. Proximal anastomoses were performed with a side-biting aortic clamp, with systemic pressures that were dictated by individual surgeon preference. The target ACT during surgery was 300. Normothermia was maintained by using warm intravenous fluids, heating mattress and a humidified airway, in addition to maintaining a warm operating theatre. A standby perfusionist with primed bypass circuit was available for all OPCAB cases.

2.3 Flow cytometry
2.3.1 Platelet–monocyte conjugate analysis
Blood was drawn preoperatively and at 2 h post-bypass and anti-coagulated with sodium citrate. Platelet–monocyte conjugate formation was analysed by tricolour flow cytometry using whole blood as described by us previously [5]. Briefly, whole blood was diluted (3:7) in a modified Tyrode's buffer and 100 µl aliquots were fixed with 1% paraformaldehyde and stained with the following monoclonal antibodies: pan-leucocyte marker CD45-FITC, the monocyte marker CD14-ECD and the platelet marker CD42b-PE (Beckman Coulter). The monocyte population was identified using CD45-FITC and CD14-ECD fluorescence, and then CD42b-PE was used to calculate the percentage of platelets adherent to the monocyte sub-population.

TF expression was determined using whole blood prepared as described above and stained with the pan-leucocyte marker CD45-PE, the monocyte marker CD14-ECD and the anti-human TF-FITC (America Diagnostica, Stamford, CT, USA). The monocyte population was identified using CD45-FITC and CD14-ECD fluorescence, and then mean TF fluorescence on the monocyte population was used to calculate the mean relative fluorescent intensity (RFI) of staining, calculated by dividing the mean fluorescent staining intensity of the anti-TF antibody at any given time point by the staining intensity of a class-matched and fluorochrome matched control antibody.

2.4 Statistical analysis
Continuous variables were expressed as mean ± SD. p-values ≤0.05 were considered statistically significant. We evaluated the effect of several factors on blood loss by using stepwise multivariable regression analysis with both forward and backward variable selection. Changes in the monocyte and platelet counts over time were considered as repeated measures data and analysed by using Generalised Estimating Equations (GEE) [6,7]. Marginal models (unstructured correlation matrix) based on generalised estimation equations were used to perform regression analysis. Variables significant at the 5% level were retained in the final multivariable models. Analysis was conducted by using the statistical software SPSS version 12.0 for Windows (SPSS Inc., Chicago, IL, USA), and Intercooled Stata version 8.0 for Windows (Stata Corporation, USA).


    3. Results
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Discussion
 References
 
3.1 Monocyte response to cardiac surgery and factors affecting the response
3.1.1 In more complex cardiac surgery
More complex cardiac surgery was defined as either redo-operations or multiple procedures (at least two of coronary or valve or aortic surgery). We observed that patients having redo-operations did not mount a different monocytic response to those having first time surgery (beta coefficient = –0.003, p = 0.95 and 95% CI –0.14 to 0.13). Patients having complex operations again did not show a difference in the monocytic response to surgery (beta coefficient = –0.02, p = 0.18 and 95% CI –0.06 to 0.12).

3.1.2 In off-pump coronary surgery
We next ascertained how the above findings compared to the response of these cells in off-pump coronary surgery. It was apparent that at every postoperative time point, monocyte counts were significantly higher in the off-pump group when compared with the on-pump group having coronary surgery (beta coefficient = –0.07, p = 0.03 and 95% CI –0.14 to –0.01) and significantly, higher platelet counts directly predicted a greater monocytic response (beta coefficient = 0.0004, p = 0.003, 95% CI 0.0004 to 0.0007).

3.1.3 In first time on-pump coronary surgery
Changes in total white blood cell (WBC), monocyte and platelet counts are shown in Fig. 1 . The WBC significantly increased following surgery (p < 0.001). A rapid peak by the second postoperative day was followed by a moderate drop on the third, fourth and fifth day. This was followed by a second rise by the sixth and seventh postoperative days. The monocyte count was seen to similarly increase on the first two postoperative days, but then in contrast to the WBC continued to rise steadily until the fifth postoperative day. Using the monocyte%, it was apparent that the initial rise in the monocyte count was a reflection of the rise in the total WBC. In contrast, over subsequent days an absolute monocytosis was seen, independent of total WBC. In comparison, the platelet count mirrored the WBC initially and showed a trough by the second postoperative day. This was followed by a subsequent rise that was significantly above the preoperative levels after the sixth postoperative day.


Figure 1
View larger version (12K):
[in this window]
[in a new window]
 
Fig. 1. Changes in white cell, monocyte and platelet counts from preoperative levels to the end of the first postoperative week. PRE denotes preoperative and PO denotes postoperative with the numerical value being the postoperative day of the sample.

 
Factors associated with relative monocytosis after on-pump coronary surgery were studied using multivariable regression analysis. Variables analysed are shown in Table 1. Patients with a higher body mass index (BMI) had a greater increase in M% (p = 0.02), as did diabetic patients (p = 0.035) and patients who smoked (p = 0.01). In contrast, older patients manifested a lower monocytic response to cardiac surgery (p < 0.001). Interestingly, myocardial protection using cross-clamp fibrillation as opposed to cardioplegia was associated with a significantly lower monocytic response postoperatively (p = 0.048). These results are shown in Table 2 .


View this table:
[in this window]
[in a new window]
 
Table 2. Multivariate analysis of factors affecting the change in monocyte% after coronary artery bypass grafting
 
The regression equation is as follows:


Formula

where {Delta}Mo: the change in monocyte fraction, A: age in years, BMI: body mass index, DM: diabetic status (non-diabetic = 0, diabetic = 1), S: smoking status (non-smoker = 0, smoker = 1) and MP: the type of myocardial protection used (cross-clamp fibrillation = 0, cardioplegia = 1).

3.2 Platelet–monocyte conjugate formation and role of TF
Since monocytes exert some of their potential haemostatic effects in association with the formation of PMCs, we characterised actual PMC formation in association with on-pump coronary surgery. PMC formation (Fig. 2 ) did not initially demonstrate a significant change although a slight downward trend following administration of heparin, followed by a subsequent peak at 5 min following the onset of CPB was seen. In contrast, 2 h after the onset of CPB, a significant decline in circulating PMCs was observed (p = 0.04). A rise and return towards preoperative levels was then found between 24 h and 5 days postoperatively.


Figure 2
View larger version (9K):
[in this window]
[in a new window]
 
Fig. 2. Formation of platelet–monocyte conjugates. The percentage of monocytes forming conjugates with platelets is indicated by the day of the sample. PRE denotes preoperative and subsequent samples are immediately after the administration of heparin, after 5 min of bypass, at the end of bypass, at 2 h and at 24 h after bypass and on postoperative day 5.

 
Since circulating monocyte TF expression may itself exert haemostatic effects and influence PMC formation, we used flow cytometric analysis to characterise this parameter perioperatively (Fig. 3 ). We were unable to detect any significant change in monocyte TF expression in association with on-pump coronary surgery.


Figure 3
View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3. (A) Colour densitometry plot showing leucocyte populations defined using pan-leucocyte marker (CD-45-PE) on the x-axis and monocyte marker (CD14-ECD) on the y-axis. (B) A histogram plot showing (on the y-axis) fluorescence of monocyte bound tissue factor (Tissue Factor-PE).

 
3.2.1 Contribution of monocytes to early postoperative blood loss
Having characterised potential monocyte haemostatic responses and levels of PMC formation perioperatively, we next studied the effects of absolute numbers of circulating platelets and monocytes on postoperative blood loss (Table 3 ). The chest drain output in the first 12 postoperative hours was used as a measure of postoperative blood loss. The mean postoperative blood loss in millilitres was 581.2 ± 292.8. Blood loss was found to be inversely related to increasing preoperative platelet count, in an exponential rather than linear manner. On this basis, platelet counts were categorised into three groups based on tertiles (platelet count <123 x 109 l–1, platelet count (123–160) x 109 l–1, and platelet count >160 x 109 l–1). Our analysis demonstrated that postoperative blood loss was decreased significantly by preoperative platelet counts >160 x 109 l–1 (p < 0.001), and also by higher preoperative monocyte counts (p = 0.012). Furthermore, female patients (p < 0.001), patients with higher body mass indices (p < 0.001), higher core body temperatures during surgery (p = 0.013) and the use of aprotinin perioperatively (p < 0.001) all contributed significantly towards decreasing the postoperative blood loss.


View this table:
[in this window]
[in a new window]
 
Table 3. Multivariate analysis of factors affecting postoperative blood loss after coronary artery bypass grafting
 
The regression equation is as follows:

Blood loss (ml) in 12 h = 1391.69 – 132.50(gender) – 8.26(core body temperature in °C) – 12.74(BMI) – platelet count(0.933) – 7.9(monocyte%) – 117.49(aprotinin) [gender = 1 for male or gender = 2 for female; platelet count as x109 l–1 if platelet count >160 x 109 l–1; aprotinin = 0 if not used and aprotinin = 1 if used].


    4. Discussion
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Discussion
 References
 
4.1 Findings of study
In our study, we observed that the monocytosis that occurred after surgery was more pronounced with off-pump surgery than with on-pump coronary surgery. It is well appreciated in the literature that off-pump surgery is associated with less postoperative bleeding [8]. The contribution of monocytes to postoperative bleeding may potentially play a role in this difference in postoperative bleeding as we observed that both circulating platelet and monocyte counts were inversely related to postoperative blood loss following on-pump coronary surgery. The impact of cardiopulmonary bypass on platelet function and postoperative haemostasis is well known and has previously been reviewed by our group [9]. In contrast, a potential haemostatic role for circulating monocytes has only been suggested from basic science studies and has never previously been investigated in the clinical setting of cardiac surgery. Our data using multivariable analysis suggest for the first time that a higher postoperative monocyte% significantly and independently decreases postoperative blood loss. Haemostatic mechanisms involved may include monocyte TF interactions with clotting factor VII and platelets as previously described [10–12] and also elaborated in Section 1. Activated platelets are known to adhere to blood monocytes, and this adhesion is mainly mediated by the surface exposure of the platelet granule protein CD62P (P-selectin). Platelets as well as platelet-derived microvesicles contain and transfer TF (the most important initiator of intravascular thrombin and fibrin formation), to monocytes in addition to decrypting monocyte TF. This potentially helps plug surgically transacted vasculature by activating the clotting cascade around platelet–monocyte conjugates.

A further observation was that patients with higher core body temperatures during coronary artery bypass grafting (relatively normothermic patients) were less likely to bleed in the postoperative period. Lower body temperatures may impair enzyme activity involved in the coagulation cascade. This is supported by in vitro studies, which have demonstrated that the clotting time of normal human plasma as measured by the activated partial thromboplastin times (APTT), pro-thrombin times (PT) and thrombin times (TT) is significantly prolonged by lower temperatures in an exponential manner [13]. Furthermore, it is also known that a lower body temperature during cardiopulmonary bypass causes increased platelet activation [14] and these preactivated platelets are dysfunctional in the postoperative period. However, hypothermia may also affect monocyte function. This possibility is supported by in-vitro human monocyte studies in which the temperature dependence of their active uptake of colloidal gold particles has been demonstrated by electron microscopy [15].

The late increase in PMCs detected in peripheral blood may be related to the observed increase in absolute numbers of available monocytes and platelets or due to their increased affinity as a result of cellular activation. In keeping with this, work by Wahba and Videm [16] has shown that platelets increase both in number and in state of activation towards the end of the first week after cardiac surgery. Although monocyte up-regulation of surface TF would theoretically further contribute to PMC formation through platelet–P-selectin interaction, we did not, in this study, detect any significant change in expression perioperatively. Therefore, the late rise in circulating PMCs following cardiac surgery is likely to be related to the observed monocytosis and thrombocytosis that occurs at the end of the first postoperative week and/or maybe mediated through TF-independent interactions. This increased number of circulating PMCs if reflective of an increased adhesive state, may potentially mediate thrombo-embolic phenomena that contribute to early graft occlusion as well as to neurological sequelae such as amaurosis fugax and other forms of transient ischaemic attack (TIAs) towards the end of the first postoperative week. The presence of significantly higher numbers of pro-thrombotic platelet–monocyte aggregates in patients with TIAs or stroke has previously been demonstrated in a non-surgical setting [17]. Interestingly, previous studies have demonstrated that the presence of circulating PMCs immediately postoperatively can act as a predictor of lower limb graft occlusion within the first six months following peripheral vascular surgery [18].

In agreement with earlier work, our study confirms that aprotinin decreases postoperative blood loss. This is thought to be in-part mediated by its anti-fibrinolytic affect. However, our group recently demonstrated that aprotinin also decreases thrombin-induced activation of platelets, whilst not inhibiting platelet aggregation induced by collagen and ADP [19]. Peak monocyte–platelet conjugate formation has been shown to be significantly reduced by aprotinin [20] and may protect both platelets and monocytes from activation by thrombin generated during cardiopulmonary bypass, allowing more effective haemostasis at the sites of surgical trauma postoperatively.

4.2 Potential impact of results on current practice
Leucocyte-depleting filters used in cardiac surgery have been shown to bind monocytes and platelets [21]. We observe platelet–monocyte conjugate formation to be at its lowest at 2 h after discontinuation of bypass, coinciding with the immediate postoperative period during which both platelet counts and function are depleted. The use of leucocyte depleting filters is likely to activate and entrap, and further decrease platelets and monocytes and PMCs, thereby reducing their availability for postoperative haemostasis [22]. Thus, it may be that they are best avoided in patients with preoperative risk factors likely to contribute to a higher risk of postoperative bleeding.

4.3 Potential future clinical use of results
In patients having postoperative bleeding diatheses despite transfusion of fresh frozen plasma and platelets and exclusion of a surgical cause, it is potentially conceivable that the contribution of monocytes to postoperative bleeding either directly or in conjunction with platelet interactions may be quantitatively more significant. The role of monocyte transfusions in these patients has not been explored despite leukapheresis having been recently shown to be a safe and efficient procedure for collecting large numbers of peripheral blood monocytes from donors [23]. Awareness of the complimentary effect between platelets and monocytes in reducing postoperative blood loss may thus be of use in developing new strategies for the management of patients having postoperative bleeding diatheses not controlled by standard measures.

4.4 Weaknesses of the study
Despite the monocyte count influencing postoperative blood loss, the absolute volume decrease appears small in relation to the contribution made by the platelet count. Nonetheless this interaction has not been studied previously. The monocytic mechanisms underlying these observations remain unclear, but do not appear to relate to monocyte TF up-regulation. Further mechanisms that may play a role will need to be addressed by a study entirely dedicated towards unravelling these processes. A further weakness is that the influence on postoperative bleeding seen in the study relates only to on-pump coronary surgery. We have mapped the response in off-pump surgery, but do not have the data to extrapolate the findings to postoperative blood loss in off-pump surgery.

The results of this study are clearly of a preliminary nature into platelet–monocyte behaviour after on-pump coronary surgery and we hope will stimulate further investigation.


    Acknowledgments
 
We are grateful to Dr Rumana Omar of the Department of Statistics, University College London, for the statistical analysis of this study.


    References
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Discussion
 References
 

  1. Shibamiya A, Tabuchi N, Chung J, Sunamori M, Koyama T. Formation of tissue factor-bearing leukocytes during and after cardiopulmonary bypass. Thromb Haemost 2004;92:124-131.[Medline]
  2. Zillmann A, Luther T, Muller I, Kotzsch M, Spannagl M, Kauke T, Oelschlagel U, Zahler S, Engelmann B. Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. Biochem Biophys Res Commun 2001;281:603-609.[CrossRef][Medline]
  3. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, Maquelin KN, Roozendaal KJ, Jansen PG, ten Have K, Eijsman L, Hack CE, Sturk A. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997;96:3534-3541.[Abstract/Free Full Text]
  4. Osterud B. The role of platelets in decrypting monocyte tissue factor. Semin Hematol 2001;38(4 Suppl. 12):2-5.
  5. Day JR, Punjabi PP, Randi AM, Haskard DO, Landis RC, Taylor KM. Clinical inhibition of the seven-transmembrane thrombin receptor (PAR1) by intravenous aprotinin during cardiothoracic surgery. Circulation 2004;110:2597-2600.[Abstract/Free Full Text]
  6. Liangand KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.[Abstract/Free Full Text]
  7. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a Generalized Estimating Equation approach. Biometrics 1988;44:1049-1060.[CrossRef][Medline]
  8. Wijeysundera DN, Beattie WS, Djaiani G, Rao V, Borger MA, Karkouti K, Cusimano RJ. Off-pump coronary artery surgery for reducing mortality and morbidity meta-analysis of randomized and observational studies. J Am Coll Cardiol 2005;46:872-882.[Abstract/Free Full Text]
  9. Weerasinghe A, Taylor KM. The platelet in cardiopulmonary bypass. Ann Thorac Surg 1998;66:2145-2152.[Abstract/Free Full Text]
  10. Wildgoose P, Kazim AL, Kisiel W. The importance of residues 195–206 of human blood clotting factor VII in the interaction of factor VII with tissue factor. Proc Natl Acad Sci USA 1990;87:7290-7294.[Abstract/Free Full Text]
  11. Amirkhosravi A, Alexander M, May K, Francis DA, Warnes G, Biggerstaff J, Francis JL. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay. Thromb Haemost 1996;75:87-95.[Medline]
  12. Furie B, Furie BC. P-selectin induction of tissue factor biosynthesis and expression. Haemostasis 1996;26(Suppl. 1):60-65.
  13. Reed RL, Bracey AW, Hudson JD, Miller TA, Fischer RP. Hypothermia and blood coagulation: dissociation between enzyme activity and clotting factor levels. Circ Shock 1990;32:141-152.[Medline]
  14. Speziale G, Ferroni P, Ruvolo G, Fattouch K, Pulcinelli FM, Lenti L, Gazzaniga PP, Marino B. Effect of normothermic versus hypothermic cardiopulmonary bypass on cytokine production and platelet function. J Cardiovasc Surg (Torino) 2000;41:819-827.[Medline]
  15. Aonuma K. Colloidal gold uptake as a marker for monocyte differentiation and maturation in normal and leukemic cells. Int J Hematol 1992;55:265-274.[Medline]
  16. Wahba A, Videm V. Heart surgery with extracorporeal circulation leads to platelet activation at the time of hospital discharge. Eur J Cardiothorac Surg 2003;23:1046-1050.[Abstract/Free Full Text]
  17. Garlichs CD, Kozina S, Fateh-Moghadam S, Tomandl B, Stumpf C, Eskafi S, Raaz D, Schmeißer A, Yilmaz A, Ludwig J, Neundörfer B, Daniel WG. Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. Stroke 2003;34:1412-1418.[Abstract/Free Full Text]
  18. Esposito CJ, Popescu WM, Rinder HM, Schwartz JJ, Smith BR, Rinder CS. Increased leukocyte-platelet adhesion in patients with graft occlusion after peripheral vascular surgery. Thromb Haemost 2003;90:1128-1134.[Medline]
  19. Poullis M, Manning R, Laffan M, Haskard DO, Taylor KM, Landis RC. The antithrombotic effect of aprotinin: actions mediated via the protease-activated receptor 1. J Thorac Cardiovasc Surg 2000;120:370-378.[Abstract/Free Full Text]
  20. Greilich PE, Brouse CF, Rinder CS, Smith BR, Sandoval BA, Rinder HM, Eberhart RC, Jessen ME. Effects of epsilon-aminocaproic acid and aprotinin on leukocyte-platelet adhesion in patients undergoing cardiac surgery. Anesthesiology 2004;100:225-233.[CrossRef][Medline]
  21. Henschler R, Ruster B, Steimle A, Hansmann HL, Walker W, Montag T, Seifried E. Analysis of leukocyte binding to depletion filters: role of passive binding, interaction with platelets, and plasma components. Ann Hematol 2005;84:538-544.[CrossRef][Medline]
  22. Ilmakunnas M, Pesonen EJ, Ahonen J, Ramo J, Siitonen S, Repo H. Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass. J Thorac Cardiovasc Surg 2005;129:851-859.[Abstract/Free Full Text]
  23. Wolf CE, Meyer M, Riggert J. Leukapheresis for the extraction of monocytes and various lymphocyte subpopulations from peripheral blood: product quality and prediction of the yield using different harvest procedures. Vox Sang 2005;88:249-255.[CrossRef][Medline]



This article has been cited by other articles:


Home page
PerfusionHome page
P. Farneti, S Sbrana, D Spiller, A. Cerillo, F Santarelli, D Di Dario, P. Del Sarto, and M Glauber
Reduction of blood coagulation and monocyte-platelet interaction following the use of a minimal extracorporeal circulation system (Synergy(R)) in coronary artery bypass grafting (CABG)
Perfusion, January 1, 2008; 23(1): 49 - 56.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Arjuna Weerasinghe
Pandelis Philippidis
Jonathan Day
Kaushik Mandal
Jonathan Anderson
Kenneth Taylor
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weerasinghe, A.
Right arrow Articles by Taylor, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weerasinghe, A.
Right arrow Articles by Taylor, K.
Related Collections
Right arrow Cardiac - other
Right arrow Coronary disease
Right arrow Extracorporeal circulation
Right arrow Molecular biology


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS